The Life Science Washington Institute Lunch & Learn webinar series has concluded as we evolve our programming to better serve today’s life science leaders.
We are excited to introduce our Executive Insights Series, a new, free, in-person experience designed for C-suite executives and senior leaders from early-stage to mid-sized life science companies. Executive Insights offers deeper, more targeted conversations, direct access to experienced and hard to reach founders, investors, and operators, and meaningful opportunities to build relationships that accelerate growth.
Explore the Executive Insights Series and upcoming sessions here.
2025 Series
December 15, 2025
Join Fenwick and Life Sciences Washington Institute for a timely discussion on financing pathways for emerging and growth-stage life sciences companies. Partners Amanda Rose and Kat Duncan will unpack the current fundraising landscape, highlight key trends shaping venture and public markets, and share practical guidance on preparing for significant transactions – from late-stage financings to strategic exits. Attendees will gain actionable insights to help position their companies for success in today’s evolving market.
PAST EVENTS
June 26, 2025
Join us for a presentation on patent strategies for life sciences startups. Whether your company is developing small molecules, large molecules, or complex biologics like cell and gene therapies, navigating the IP landscape is critical to securing long-term value and competitive advantage. This session will provide an introduction to patent filing timelines, exclusivity strategies, and lessons from common pitfalls.
2024 Series
December 10, 2024
Navigating Clinical Data: Disclosure, Financing, and other Practice Considerations
Join the Life Science Washington Institute and Fenwick for a discussion on the key considerations surrounding the receipt and disclosure of clinical data in the life sciences sector. Our speakers will cover disclosure obligations, financing impacts, and best practices to ensure compliance and strategic advantage. This session is designed to provide valuable insights for business professionals navigating this complex landscape.
October 29, 2024
Check’s in the Mail: An Introduction to Startup Funding
Colleen Badgley and Alan Hambelton from Cooley LLP will discuss typical funding structures, terms and process for startup companies. From term sheet to closing, you’ll learn about convertible notes, SAFEs, Seeds and Series A.
May 14, 2024
Data Protection Nuts & Bolts
In this primer, we will explore what early-stage life sciences companies need to know about data protection and provide practical tips to address it. Not simply a compliance exercise, data protection is increasingly a commercial imperative. Implementing and maintaining foundational measures can lead to the ability to successfully leverage one of life science companies’ critical assets: its data.
May 30th, 2024
Navigating the Future: Market Trends in the Life Sciences Industry
2023 was a difficult year for the life science industry. The financing environment was slow, and IPOs were nearly nonexistent. However, the outlook for 2024 is much more optimistic. Join us for a discussion with Fenwick capital markets partner Amanda Rose and financing partner Kat Duncan on the current state of the life sciences industry and the trends and challenges shaping the financial landscape in 2024 and beyond.
Contact Aylin Kim, Director of Entrepreneurship, with any questions or for more information aylin@lswinstitute.org!